PI3K/MEK pathway-targeted therapy in non-small cell lung carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PI3K/MEK pathway-targeted therapy in non-small cell lung carcinoma

Published:2015-11-27 Issue:1 Volume:2 Page:1114709
ISSN:2331-205X
Container-title:Cogent Medicine
language:en
Short-container-title:Cogent Medicine

Author:

Ahmad Ali¹,Jafar Ali²³,Alshatti Yaqoub¹

Affiliation:

1. Department of Internal Medicine, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait

2. Department of Surgical & Interventional Sciences, University College London (UCL), London, UK

3. Division of Surgical and Interventional Sciences, Royal Free Hospital, London, UK

Publisher

Informa UK Limited

Subject

Applied Psychology,General Biochemistry, Genetics and Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/2331205X.2015.1114709

Reference75 articles.

1. Diagnosis and Management of Lung Cancer Executive Summary

2. A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer

3. Genetics of lung-cancer susceptibility

4. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls

5. A New Mutational aktivation in the PI3K Pathway

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP